The Indian API market is estimated to witness a growth rate of over 9.5% during the forecast period. India is one of the emerging economies globally and a major player in the global API market. Rising prevalence of chronic diseases such as cancer and cardiovascular diseases (CVDs), presence of several medium to large API manufacturers, and increasing focus of government on the development of pharmaceutical manufacturing sector are some of the factors that are boosting the country’s API market. As per the government of Uttarakhand, India has a market share of 20% in the global generic market by volume and has a network of more than 10,500 manufacturers and 3,000 pharma companies. The Indian pharmaceutical market has increased by 7.4 % and reached around $19.0 billion in 2017 and expected to reach nearly $29.0 billion in 2022. 

Visit for Global API Market Report at: https://www.omrglobal.com/industry-reports/api-market

The Indian API market is segmented on the basis of type, type of synthesis, manufacturer type, therapeutics, and region. On the basis of type, the market is divided into a generic API and branded API. The branded API segment is estimated to be the dominant segment over the forecast period. On the basis of the type of synthesis, the market is classified into biotech API, synthetic API, and others. The synthetic API segment held the dominant position in the Indian API market in 2018. Furthermore, the market is classified on the basis of therapeutics into cardiovascular drugs, oncology drugs, neurology drugs, Non-steroidal Anti-inflammatory Drugs (NSAIDs), and others.

Some of the prominent players that contribute significantly in the Indian API market include Teva Pharmaceutical Industries Ltd., Piramal Enterprises Ltd., Sun Pharmaceutical Industries Ltd., Aurobindo Pharma, Novartis International AG, Boehringer Ingelheim International GmbH, and others. Sun Pharmaceutical Industries Ltd. is one of the significant companies in the API market India. It manufactures and markets generic and branded formulations and active pharmaceutical ingredients (APIs) in India and internationally. For API, the company provides anti-cancers, steroids, peptides, sex hormones, and controlled substances. The company manufactures APIs presently in 14 units located in Hungary, Israel, India, and the US. Some of the company’s major API products include Abiraterone acetate, Acitretin, Anastrozole, Azacitidine, Bosentan Monohydrate.

Research Methodology

The market study of the Indian API market is incorporated by extensive primary and secondary research conducted by the research team at OMR.  Secondary research has been conducted to refine the available data to breakdown the market in various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior and macro-economic factors. Numbers extracted from Secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings authenticity to our reports.

Secondary Sources Include

• Financial reports of companies involved in the market.
• Authenticate databases such as the American Heart Association, the National Institute of Health, and the International Diabetes Federation.
• Whitepapers, research-papers, and news blogs.
• Company websites and their product catalog.

The report is intended for pharmaceutical and biotechnology companies, healthcare organizations, research institutes and academic institutes, pharmaceutical drug manufacturers, API manufacturers, raw material suppliers, distributors, traders, government organizations and regulatory agencies, and other market participants for overall market analysis and competitive analysis. The report provides an in-depth analysis of market size, different products, and future market opportunities. The report will serve as a source for a 360-degree analysis of the market thoroughly delivering insights into the market for making better business decisions.

Market Segmentation

1. Indian API Market Research and Analysis by Type
2. Indian API Market Research and Analysis by Type of Synthesis
3. Indian API Market Research and Analysis by Therapeutics

The Report Covers

• Comprehensive research methodology of Indian API market.
• This report also includes a detailed and extensive market overview with key analyst insights.
• An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
• Analysis of regional regulations and other government policies impacting Indian API market.
• Insights about market determinants that are stimulating Indian API market.
• Detailed and extensive market segments with regional distribution of forecasted revenues.
• Extensive profiles and recent developments of market players.